Emerging Antidementia Drugs: A Preliminary Ethical View
Post, Stephen G.
Whitehouse, Peter J.
Journal of the American Geriatrics Society. 1998 Jun; 46(6): 784-787.
What ethical concerns regarding the application of new antidementia compounds are pertinent to the best interests of patients with Alzheimer's disease and their caregivers? Based on collected preliminary anecdotal accounts, these concerns are important and should be considered carefully by clinicians, researchers, and families.
Aged; Beneficence; Caregivers; Case Studies; Decision Making; Dementia; Disease; Drugs; Economics; Family Members; Goals; Justice; Life; Morbidity; Nursing Homes; Patient Care; Patients; Prolongation of Life; Quality of Life; Researchers; Risks and Benefits; Treatment Outcome; Withholding Treatment;
Showing items related by title, author, creator and subject.
Post, Stephen G.; Whitehouse, Peter J.; Binstock, Robert H.; Bird, Thomas D.; Eckert, Sharen K.; Farrer, Lindsay A.; Fleck, Leonard M.; Gaines, Atwood D.; Juengst, Eric T.; Karlinsky, Harry; Miles, Steven; Murray, Thomas H.; Quaid, Kimberly A.; Relkin, Norman R.; Roses, Allen D.; St. George-Hyslop, P.H.; Sachs, Greg A.; Steinbock, Bonnie; Truschke, Edward F.; Zinn, Arthur B. (1997-03-12)OBJECTIVE: Primary caregivers should be aware of recent progress in the genetics of Alzheimer disease (AD) and of the clinical and ethical considerations raised regarding the introduction of genetic testing for purposes ...